Related Experiment Videos
The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial
Anja Frei1, Corinne Chmiel, Hansueli Schläpfer
1Institute of General Practice and Health Services Research, University of Zurich, Zurich, Switzerland. anja.frei@usz.ch
Cardiovascular Diabetology
|June 17, 2010
Summary
This study investigated if a practice nurse-led Chronic Care Model improves diabetes care in Swiss primary care. Results suggest this model may not be easily implemented in this setting, prompting a reevaluation of care redesign in Switzerland.
Area of Science:
- Primary care research
- Health services research
- Chronic disease management
Background:
- Diabetes poses significant challenges to healthcare systems and primary care providers.
- The Chronic Care Model (CCM) is an evidence-based framework for chronic illness care, with studies showing improved outcomes.
- Existing CCM research is often not set within the context of the Swiss healthcare system, which is characterized by single-handed practices.
Purpose of the Study:
- To test if implementing CCM elements via a trained practice nurse improves HbA1c levels in type II diabetes patients after one year.
- To assess if the intervention improves patient achievement of target blood pressure, HbA1c, and LDL-cholesterol levels.
- To evaluate the intervention's impact on patient quality of life (SF-36), patient-reported care experiences (PACIC-5A), and practice team experiences (ACIC).
Main Methods:
- Cluster randomized controlled trial (CARAT) with general practitioners as the unit of randomization.
- Intervention group: Practice nurse and GP trained in CCM teamwork for diabetes care.
- Control group: Usual care. 28 GPs randomized, each including 12 type II diabetes patients. Data collected at baseline and 1-year follow-up.
Main Results:
- The study challenges the hypothesis that the Chronic Care Model is easily implementable through a practice nurse-focused approach in Swiss primary care.
- Further analysis is required to determine the specific outcomes regarding HbA1c, blood pressure, and cholesterol targets, as well as quality of life and patient/team experience.
Conclusions:
- The findings question the straightforward implementation of the Chronic Care Model using a practice nurse-led strategy in the Swiss primary care context.
- If confirmed, results suggest a need to reconsider the application of this model for other chronic diseases and multimorbid patients.
- The study highlights the importance of redesigning healthcare delivery within the unique Swiss system.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...